Stay updated on Iomab-B vs Conventional Care in Older AML Clinical Trial

Sign up to get notified when there's something new on the Iomab-B vs Conventional Care in Older AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Iomab-B vs Conventional Care in Older AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T01:34:41.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-25T01:33:25.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T01:12:23.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T01:47:46.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A new revision label v3.7.0 was added to the history, and the previous revision v3.6.6 is no longer listed.
    Difference
    0.1%
    Check dated 2026-09-20T00:37:22.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    A new version entry (Revision: v3.6.6) appears in the study record history, replacing the previous v3.6.5. This indicates an update to the page history metadata.
    Difference
    0.1%
    Check dated 2026-08-29T20:12:26.000Z thumbnail image

Stay in the know with updates to Iomab-B vs Conventional Care in Older AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Iomab-B vs Conventional Care in Older AML Clinical Trial page.